An outbreak of infectious chicken anemia in fattening chickens in Switzerland]

An outbreak of infectious anaemia in 46 broiler flocks due to chicken anaemia agent (CAA) is described. The vertically acquired infection led to increased mortality (3.6-19.8%) in 16 to 24 day-old broiler chickens. At necropsy severe atrophy of thymus and anaemia with pale bone marrow was observed. The histologic findings were depletion of cortical thymocytes and of hematopoietic cells in the bone marrow. The CAA was isolated from 15 of 35 examined broiler flocks.     

Ultrastructure of the tubular glands in the isthmus region of the oviduct in laying and natural moulting commercial egg‐type chickens

The study investigated the ultrastructural characteristics of tubular gland and duct cells, as well as luminal gland cells in the isthmus region of the oviduct of laying and natural moulting hens. Tubular glands in laying birds were composed of type 1 and 2 cells. Based on the preponderance of each cell type, in relation to the location of a developing egg in the oviduct of the domestic fowl, these gland cells may represent different functional states of the same cell. The findings of the study on natural moulting birds suggest that autophagy is a process confined to the early stages of degeneration, while necrosis occurs in the terminal stages.     

SoilFlex‐LLWR: linking a soil compaction model with the least limiting water range concept

Soil compaction impacts growing conditions for plants: it increases the mechanical resistance to root growth and modifies the soil pore system and consequently the supply of water and oxygen to the roots. The least limiting water range (LLWR) defines a range of soil water contents within which root growth is minimally limited with regard to water supply, aeration and penetration resistance. The LLWR is a function of soil bulk density (BD), and hence directly affected by soil compaction. In this paper, we present a new model, ‘SoilFlex‐LLWR’, which combines a soil compaction model with the LLWR concept. We simulated the changes in LLWR due to wheeling with a self‐propelled forage harvester on a Swiss clay loam soil (Gleyic Cambisol) using the new SoilFlex‐LLWR model, and compared measurements of the LLWR components as a function of BD with model estimations. SoilFlex‐LLWR allows for predictions of changes in LLWR due to compaction caused by agricultural field traffic and therefore provides a quantitative link between impact of soil loading and soil physical conditions for root growth.     

Carvedilol in dogs with dilated cardiomyopathy

BACKGROUND: Dilated cardiomyopathy (DCM) is characterized by reduced systolic function, heightened sympathetic tone, and high morbidity and mortality. Little is known regarding the safety and efficacy of beta-blocker treatment in dogs with DCM. HYPOTHESIS: Carvedilol improves echocardiographic and neurohormonal variables in dogs with DCM over a 4-month treatment period. METHODS: Prospective, placebo-controlled, double-blinded randomized study. Dogs with DCM underwent echocardiography, ECG, thoracic radiographs, and neurohormonal profiling, followed by titration onto carvedilol (0.3 mg/kg q12h) or placebo over a 4-week period and subsequently received 3 months of therapy. Primary study endpoints included left ventricular volume and function. RESULTS: Sixteen dogs received carvedilol and 7 received placebo. At study end, 13 carvedilol dogs and 5 placebo dogs were alive. There was no difference in the mean percentage change in left ventricular volume at end-diastole (LVVd), left ventricular end-systolic volume (LVVs), and ejection fraction (EF) between treatment groups, suggesting that both groups experienced similar amounts of disease progression. Carvedilol treatment did not result in significant changes in neurohormonal activation, radiographic heart size, heart rate, or owner perceived quality-of-life. Baseline B-type natriuretic peptide (BNP) predicted dogs in the carvedilol-treated group that maintained or improved their EF over the study duration. CONCLUSIONS AND CLINICAL IMPORTANCE: Carvedilol administration did not improve echocardiographic or neurohormonal indicators of heart function. The lack of effect may be related to severity of disease, carvedilol dose, or brevity of follow-up time. Statistical power of the present study was adversely affected by a high fatality rate in study dogs and small sample size.